SEC Form 4/A · accession 0000899243-17-010314
INFINITY PHARMACEUTICALS, INC. · INFI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Adelene Q Perkins
Officer — Chief Executive Officer · Director
Period of report
Oct 31, 2016
Accepted (ET)
Apr 14, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 31, 2016 | A | 85,800 | $0.00 | A | 449,220 | D | |
| Common Stock | holding | — | — | — | 9,055 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested in full on October 31, 2016.
- F2This amendment is being filed to correct the total amount of securities beneficial owned following the reported transaction to reflect 1,809 shares of common stock purchased through the issuer's Employee Stock Purchase Plan on June 30, 2016.